ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Risk Prediction Improved In Atypia Cases

July 27, 2007

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001

In Brief: Panel to Meet Jan. 30 In Los Angeles; Fate Of Proposed Urologic Group Depends On Budget

January 10, 1986

Roswell Park Wins $2.8 Million Grant

July 31, 2009

Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available

January 5, 1990

Budge Act Includes Language On Coverage Of Oral Cancer Drugs

August 13, 1993